NCT04081766

Brief Summary

This study involves two parts: a randomised controlled trial, and a nested qualitative study. The main aim of the trial is to evaluate the effectiveness of a pharmacist-led, medications-focused patient counselling on reducing the frequency of hypoglycaemia in older adults diagnosed with type 2 Diabetes Mellitus within 12 weeks in Jordan. The study hypothesis is that individualised patient counselling which is provided by pharmacists and involves recommendations about anti-diabetic medications will reduce the risk of hypoglycaemia by preventing further episodes in the elderly Jordanians with type 2 Diabetes Mellitus. The qualitative study aims at evaluating the experience of participants in both groups with the study (process evaluation). This involves exploring which components are effective and which are not with the reasons, the contextual factors affecting the delivery and implementation of the study and the intervention, and how the study and the intervention can be scaled up in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 9, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 9, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

April 22, 2021

Status Verified

November 1, 2020

Enrollment Period

11 months

First QC Date

September 4, 2019

Last Update Submit

April 21, 2021

Conditions

Keywords

Diabetes Mellitus, Type 2Diabetes MellitusHypoglycemiaCounselingOlder Adults

Outcome Measures

Primary Outcomes (1)

  • Frequency of total episodes of hypoglycaemia

    The frequency of hypoglycemia will be calculated as the number of total hypoglycemic episodes/person/ 12 weeks. Total hypoglycemia is defined as the summation of severe, symptomatic, and asymptomatic episodes of hypoglycaemia.

    12 weeks

Secondary Outcomes (5)

  • Frequency of severe hypoglycaemia

    12 weeks

  • Frequency of asymptomatic hypoglycemia

    12 weeks

  • Frequency of symptomatic hypoglycemia

    12 weeks

  • Proportion of patients experiencing hypoglycaemia

    12 weeks

  • Time to the first hypoglycaemic attack

    12 weeks

Study Arms (2)

SUGAR Handshake

ACTIVE COMPARATOR

Participants assigned to the intervention group will receive an individualised, pharmacist-led patient counselling session (SUGAR Handshake package) at the inclusion visit. Participants will also receive a pictogram with the main instructions for easy recall of the counselling contents. They will also receive a glucometer and test strips with a demonstration on proper use, to measure their fasting blood glucose levels on a daily basis for 12 weeks. At week 6, participants will receive a phone call to reinforce the intervention and to remind them of the study protocol. For the qualitative evaluation of the intervention, a number of participants are interviewed and asked questions through the sixth week-phone call. Additionally, participants in this group will be provided with the usual care that is normally provided in the outpatient clinics at King Abdullah University Hospital.

Behavioral: SUGAR Handshake

Control

NO INTERVENTION

Participants within this group will receive the usual care provided by the health care professionals in the outpatient clinics at King Abdullah University Hospital. They will also be provided with instructions on hypoglycemia diagnosis, and treatment and a demonstration on glucometer use at the inclusion visit. They will be asked to measure their fasting blood glucose level daily for 12 weeks. Participants will receive a phone call at week 6 of the inclusion visit to remind them of measuring blood glucose levels and documenting hypoglycemic episodes on the diaries., plus a counselling session about hypoglycaemia recognition and treatment at the inclusion visit. For the qualitative evaluation of the study, a number of participants will be interviewed and asked questions through the sixth week-phone call.

Interventions

SUGAR HandshakeBEHAVIORAL

An interactive patient counselling session delivered by a pharmacist which mainly focuses on medication-related instructions towards preventing hypoglycaemia in addition to recommendations about hypoglycemia early recognition, causes, and treatment. The SUGAR Handshake is individualised according to shared decision making and each participant's characteristics. Components of the SUGAR Handshake intervention will be covered under five main domains: 1. Signs and symptoms of hypoglycemia. 2. Understanding the underlying causes of hypoglycaemia such as misuse of anti-diabetic medications. 3. Good glycaemic control and self-monitoring, which mainly includes instructions on handling the anti-diabetic medications. 4. Acknowledgement by the patient 5. Recap and summary The pictogram contains the main recommendations for easy recall by the participant. Moreover, the intervention will be reinforced by a phone call at week 6 of the inclusion visit.

SUGAR Handshake

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Confirmed diagnosis of type 2 Diabetes Mellitus
  • Have been taking a sulfonylurea, insulin, or any three or more anti-diabetic medications

You may not qualify if:

  • Unable to understand instructions or to give consent.
  • Impaired mental capacity
  • On palliative care for cancer, with advanced-stage or end-stage diseases, who have psychosis or severe depression, who are terminally-ill, or with life expectancy \< 6 months
  • Have been diagnosed with haemolytic anaemia or hemoglobinopathies as being self-reported or according to the patient's electronic record.
  • Unwilling to take home glucose measurements or to use the glucometer (for example because of severe hearing or visual impairment and without a caregiver to measure the blood glucose level by the glucometer)
  • Unwilling to return for follow up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Abdullah University Hospital

Irbid, 22110, Jordan

Location

Related Publications (2)

  • Almomani HY, Ayre HM, Powell RA, Armani K. The SUGAR handshake intervention to prevent hypoglycaemia in elderly people with type 2 diabetes: process evaluation within a pragmatic randomised controlled trial. BMC Geriatr. 2025 Oct 1;25(1):753. doi: 10.1186/s12877-025-06361-2.

  • Almomani HY, Pascual CR, Al-Azzam SI, Ahmadi K. Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention. Res Social Adm Pharm. 2021 May;17(5):885-893. doi: 10.1016/j.sapharm.2020.07.012. Epub 2020 Jul 29.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes MellitusHypoglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Keivan Ahmadi, PhD

    Associate Professor in Pharmacology & Therapeutics, Lincoln Medical School

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2019

First Posted

September 9, 2019

Study Start

February 9, 2020

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

April 22, 2021

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations